Extracellular Vesicles in Epstein-Barr Virus Pathogenesis
PURPOSE OF REVIEW: Epstein-Barr virus (EBV) is a known determinant for numerous malignancies and may contribute to autoimmune diseases. The underlining mechanisms behind EBV pathologies is not completely understood. Recently, extracellular vesicles (EVs) released from infected cells have been found to produce profound effects on cellular microenvironments. Therefore, in this review we sought to critically evaluate the roles of EVs in EBV pathogenesis and assess their potential therapeutic and diagnostic utility.
RECENT FINDINGS: EBV-altered EVs are capable of activating signaling cascades and phenotypic changes in recipient cells through the transfer of viral proteins and RNAs. Moreover, several EV-associated microRNAs have encouraging prognostic or diagnostic potential in EBV-associated cancers.
SUMMARY: Current evidence suggests that EBV-modified EVs affect viral pathogenesis and cancer progression. However, further research is needed to investigate the direct role of both viral and host products on recipient cells and the mechanisms driving viral protein and RNA EV packaging and content modification.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
Current clinical microbiology reports - 6(2019), 3 vom: 10. Sept., Seite 121-131 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cone, Allaura S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Autoimmune |
|---|
| Anmerkungen: |
Date Revised 12.04.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s40588-019-00123-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM306461021 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM306461021 | ||
| 003 | DE-627 | ||
| 005 | 20231225123421.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40588-019-00123-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1021.xml |
| 035 | |a (DE-627)NLM306461021 | ||
| 035 | |a (NLM)32051811 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cone, Allaura S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Extracellular Vesicles in Epstein-Barr Virus Pathogenesis |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 12.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a PURPOSE OF REVIEW: Epstein-Barr virus (EBV) is a known determinant for numerous malignancies and may contribute to autoimmune diseases. The underlining mechanisms behind EBV pathologies is not completely understood. Recently, extracellular vesicles (EVs) released from infected cells have been found to produce profound effects on cellular microenvironments. Therefore, in this review we sought to critically evaluate the roles of EVs in EBV pathogenesis and assess their potential therapeutic and diagnostic utility | ||
| 520 | |a RECENT FINDINGS: EBV-altered EVs are capable of activating signaling cascades and phenotypic changes in recipient cells through the transfer of viral proteins and RNAs. Moreover, several EV-associated microRNAs have encouraging prognostic or diagnostic potential in EBV-associated cancers | ||
| 520 | |a SUMMARY: Current evidence suggests that EBV-modified EVs affect viral pathogenesis and cancer progression. However, further research is needed to investigate the direct role of both viral and host products on recipient cells and the mechanisms driving viral protein and RNA EV packaging and content modification | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Epstein-Barr virus | |
| 650 | 4 | |a autoimmune | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a diagnostic | |
| 650 | 4 | |a exosomes | |
| 650 | 4 | |a extracellular vesicles | |
| 700 | 1 | |a York, Sara B |e verfasserin |4 aut | |
| 700 | 1 | |a Meckes, David G |c Jr |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current clinical microbiology reports |d 2014 |g 6(2019), 3 vom: 10. Sept., Seite 121-131 |w (DE-627)NLM245019375 |x 2196-5471 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2019 |g number:3 |g day:10 |g month:09 |g pages:121-131 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40588-019-00123-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2019 |e 3 |b 10 |c 09 |h 121-131 | ||